Cargando…
Pluripotent stem cells: A therapeutic source for age-related macular degeneration
Age-related macular degeneration (AMD) leads to progressive loss of central vision in the elderly. At a cellular level, there is aging of the retinal pigment epithelial (RPE) cells, and accumulation of lipofuscin that interferes with the proper functioning of RPE which eventually leads to apoptosis....
Autores principales: | Parameswaran, Sowmya, Krishnakumar, Subramanian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426121/ https://www.ncbi.nlm.nih.gov/pubmed/28440245 http://dx.doi.org/10.4103/ijo.IJO_1026_15 |
Ejemplares similares
-
Proteomics-based approach for differentiation of age-related macular degeneration sub-types
por: Sivagurunathan, Sivapriya, et al.
Publicado: (2021) -
Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration
por: Yang, Yi-Ping, et al.
Publicado: (2022) -
Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
por: Fields, Mark, et al.
Publicado: (2016) -
Therapeutic Approaches for Age-Related Macular Degeneration
por: Galindo-Camacho, Ruth M., et al.
Publicado: (2022) -
Trends of Stem Cell Therapies in Age-Related Macular Degeneration
por: Maeda, Tadao, et al.
Publicado: (2021)